CBD has proven neuroprotective effects and its anti-cancer properties are being investigated at several academic research centers in the United States and elsewhere. A 2010 brain cancer study by California scientists found that CBD “enhances the inhibitory effects of THC on human glioblastoma cell proliferation and survival.” This means that CBD makes THC even more potent as an anticancer substance. Also in 2010, German researchers reported that CBD stimulates neurogenesis, the growth of new brain cells, in adult mammals.
We have all seen the recent news articles showcasing CBD oil and many of us would like to get involved... but where do you start? In the event you didn’t already know, there are two sources for CBD oil and other CBD/Cannabidiol products: 1.) Hemp CBD products made from industrial hemp and 2.) Medical marijuana CBD products derived from medical marijuana. One is available widely online from sites like DiscoverCBD.com and the other is available at medical marijuana dispensaries across the US in states where medical marijuana is legal.
In terms of how CBD is extracted from the cannabis plant, there a few different techniques that can be used. The most popular used to be by running harsh chemicals like butane (lighter fluid) or hexane over the raw plant material, but people quickly found out that this resulted in trace amounts of carcinogenic compounds (like formaldehyde) being left over in the end product. Not good.
Under federal law, cannabis (from which both CBD and marijuana are derived) is illegal everywhere, although the laws against it aren’t generally enforced in states that have legalized marijuana. Some manufacturers claim that CBD culled from legally imported industrial hemp, which has little to no THC, is fine to ship across the U.S., but many experts disagree, noting that because hemp comes from the same species as marijuana, cannabis sativa, all CBD falls under the DEA’s Schedule 1 designation. “This creative interpretation of the law runs afoul of reality,” says the Brookings Institution, a Washington, DC, think tank.